About Harsh International LLC
Harsh International LLC is a Healthcare company. Pharmaceutical manufacturing and services in healthcare, emphasizing innovation and global accessibility. Its Indian entity Harsh Medicose Private Limited reported revenue of ₹22.51 Cr. Harsh International LLC offers products and services including Respules and Eye/Ear Drops. Its focus areas include Services, Consulting, Project Management and Pharmaceuticals.
Company details
Harsh International LLC is recognized for its role in delivering innovative healthcare solutions, with operations driven by Harsh Medicose Pvt. Ltd., a Gujarat-based entity focused on research and product development. A commitment to valuing human life is evident in the provision of pharmaceutical services and products like Respules and IV LVP Fluid, which are designed to meet global needs while ensuring affordability and quality. Over 20 years of excellence have been achieved through customer-centric approaches and integrity in operations, including turnkey projects and plant design that support healthcare accessibility worldwide.
- SectorsHealthcare
- Email••••••••
- Website harshmedicose.com
- Legal Name Harsh Medicose Pvt. Ltd
- Date of Incorporation 02 Nov, 2018
- Jurisdiction Kalol, Gujarat, India
- Indian entity revenue₹22.51 Cr
FY 2024 · -10% YoY
- Indian entity net profit₹11.3 Lakh
FY 2024 · 1% margin
- Indian entity EBITDA₹31 Lakh
FY 2024 · 1% margin
Associated legal entities of Harsh International LLC
Harsh International LLC operates through Harsh Medicose Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Harsh Medicose Private Limited CIN U21009GJ2018PTC105078 | Active | 02 Nov 2018 | Kalol, Gujarat | ₹22.5 Cr | 3 | View details |
Products & Services of Harsh International LLC
Harsh International LLC offers a comprehensive portfolio of products and services, including Respules and Eye/Ear Drops.
Nebulizing solutions are offered for respiratory care, ensuring accessibility and effectiveness in healthcare applications
Drops are provided to enhance patient health for eye and ear conditions, with a focus on quality and affordability
Board of directors of Harsh Medicose Private Limited (Harsh International LLC)
Harsh Medicose Private Limited is the primary company behind Harsh International LLC. The board of Harsh Medicose Private Limited currently have 3 directors; the longest-serving is Harsh Bharatkumar Vihol, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harsh Bharatkumar Vihol DIN 08272774 | Director | 02 Nov 2018 | 8 yrs | Harsh Medicose Private Limited |
| Manishabahen Bharatkumar Vihol DIN 08272775 | Director | 02 Nov 2018 | 8 yrs | Harsh Medicose Private Limited |
| Bharatkumar Baluji Vihol DIN 02410827 | Director | 01 Aug 2020 | 6 yrs 3 mo | Harsh Medicose Private Limited |
Financials of Harsh International LLC
Figures of Harsh Medicose Private Limited, the primary company behind Harsh International LLC, for FY 2024. Revenue was ₹22.51 Cr (-10% year on year). Net profit was ₹11.3 Lakh (1% margin). EBITDA was ₹31 Lakh (1% margin). Revenue has grown at a compounded annual rate of +62% over three years and +156% over five years.
- ₹22.51 CrRevenue · FY 2024 · -10% YoY
- ₹11.3 LakhNet profit · 1% margin
- ₹31 LakhEBITDA · 1% margin
- ₹1 LakhPaid-up capital
- +62%Revenue CAGR, 3 years
- +156%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Harsh Medicose Private Limited are on its company page.
Detailed financial statements for Harsh International LLC
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Harsh International LLC
The primary company behind Harsh International LLC, Harsh Medicose Private Limited, reported revenue of ₹22.51 Cr for FY 2024, down 10% year on year.
Harsh International LLC is recognized for its role in delivering innovative healthcare solutions, with operations driven by Harsh Medicose Pvt. Ltd., a Gujarat-based entity focused on research and product development. A commitment to valuing human life is evident in the provision of pharmaceutical services and products like Respules and IV LVP Fluid, which are designed to meet global needs while ensuring affordability and quality. Over 20 years of excellence have been achieved through customer-centric approaches and integrity in operations, including turnkey projects and plant design that support healthcare accessibility worldwide.
Harsh International LLC offers Respules and Eye/Ear Drops.
Harsh International LLC operates through Harsh Medicose Private Limited.
The legal entities of Harsh International LLC currently have 3 directors, including Harsh Bharatkumar Vihol, Manishabahen Bharatkumar Vihol, Bharatkumar Baluji Vihol.